NCT04681105 2026-01-28Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological MalignanciesCity of Hope Medical CenterPhase 1 Completed13 enrolled
NCT04752163 2025-05-23DS-1594b With or Without Azacitidine, Venetoclax, or Mini-HCVD for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic LeukemiaM.D. Anderson Cancer CenterPhase 1/2 Terminated17 enrolled 15 charts